Clinical trials
Recruiting Hyperglycemia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Indiana University | 2 |
| University of Pittsburgh | 2 |
| Alexander T. Yahanda | 1 |
| British Columbia Cancer Agency | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Instituto Nacional de Medicina Genomica | 1 |
| Jane Yardley | 1 |
| Korea University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 33 |
| Diabetes Mellitus, Type 2 | 10 |
| Diabetes Mellitus | 7 |
| Hypoglycemia | 6 |
| Diabetes Mellitus, Type 1 | 4 |
| Hyperlipidemias | 4 |
| Hypertension | 4 |
| Obesity | 4 |
| Prediabetic State | 3 |
| Dyslipidemias | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.